We know NIV works well for patients with acute COPD or acute CHF exacerbations. In this episode we discuss the evidence for NIV not only in COPD and CHF, but also a myriad of other conditions. Do you know what the latest guidelines say on NIV for asthma, immunocompromised patients, or undifferentiated acute respiratory failure? Take a listen!
You can get CME credit for this episode hereClick here for CME Account Creation Instructions
The use of steroids in patients with sepsis and septic shock has been controversial for decades. At present, the Surviving Sepsis Campaign recommends the...
Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence....
Acute respiratory failure (ARF) is a leading cause of ICU admission, intubation, and initiating mechanical ventilation. Noninvasive respiratory support is a critical therapy used...